Volume 193, Issue 3, Supplement , Pages 1105-1109, September 2005
Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne muscular dystrophy
Objective
Duchenne muscular dystrophy (DMD) is a lethal degenerative muscular disease. Fetal gene therapy may correct the primary genetic defect. Our aim was to achieve expression of a reporter gene in the respiratory muscles of early gestation fetal sheep.
Study design
An adenovirus vector containing the β-galactosidase reporter gene (AdRSVβgal) was injected into the thoracic musculature (n
=
3) and pleural cavity (n
=
6) of fetal sheep (61-67 days' gestation) under ultrasound guidance. Tissues were harvested after 48 hours and site and intensity of β-galactosidase expression were assessed.
Results
Limited transgene expression observed after a single injection was improved by multiple injections, but remained localized. Ultrasound-guided creation of a hydrothorax led to an increase in the intensity of β-galactosidase expression (ELISA). X-gal staining and immunohistochemistry showed that vector spread was confined to the innermost intercostal musculature.
Conclusion
Ultrasound-guided injection can deliver gene therapy vectors to the fetal pleural cavity and achieve transduction of the respiratory muscles.
Key words: Gene therapy, Fetal gene therapy, Duchenne muscular dystrophy, Ultrasound, Fetal medicine
To access this article, please choose from the options below
Presented at the Twenty-Fifth Annual Meeting of the Society for Maternal Fetal Medicine, February 7-12, 2005, Reno, Nev.
PII: S0002-9378(05)00980-4
doi:10.1016/j.ajog.2005.06.077
© 2005 Mosby, Inc. All rights reserved.
Volume 193, Issue 3, Supplement , Pages 1105-1109, September 2005
